Document is current

Article History

Received: 9 August 2019

Accepted: 5 February 2020

First Online: 12 February 2020

Ethics approval and consent to participate

: Study ethics approval was obtained from CECIC Rhône-Alpes-Auvergne, Clermont-Ferrand (IRB 5891). The CECIC considering the recommended nature of the control of the prescription of high-alert medications by a hospital pharmacist and the usual character of this practice, did not raise any ethical problem with the publication of this work and judged unnecessary the request of written or verbal consent. The CECIC has allowed accessing and using the data and records described in the study. This decision was made after reviewing our project according to the French Law on Research Involving the Human Person and the Declaration of Helsinki of the World Medical Association.

: not applicable.

: The authors declare that they have no competing interests.